Cell culture in esophageal squamous cell carcinoma and the association with molecular markers

被引:0
|
作者
Shimada, Y
Maeda, M
Watanabe, G
Yamasaki, S
Komoto, I
Kaganoi, J
Kan, T
Hashimoto, Y
Imoto, I
Inazawa, J
Imamura, M
机构
[1] Kyoto Univ, Grad Sch Med, Dept Surg & Surg Basic Sci, Sakyo Ku, Kyoto 6068507, Japan
[2] Tokyo Med & Dent Univ, Med Res Inst, Dept Mol Cytogenet, Bunkyo Ku, Tokyo 1138510, Japan
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose: We reported previously that the patients in whom cancer cells could be cultured as continuous cell lines had a poor prognosis of esophageal squamous cell carcinoma (ESCC) patients. In this study, to evaluate additional evidence of prognostic significance and the genetic background of cell culture, we analyzed 203 ESCC patients. Experimental Design: Culture samples were obtained from resected 203 primary ESCC (from 1986 to 1998; R0 resection). The expression of six molecular markers was evaluated retrospectively in resected primary esophageal tumors by immunohistochemical analysis, and the capability of establishing cell lines was compared. Results: Thirty-five cell lines (17.2%) were established from 203 ESCC patients: group 1 (n = 35), from whom cancer cells could be cultured as continuous cell lines, and group 2 (n = 168), from whom cell lines could not be established. The cumulative survival rate of patients in group 1 was significantly lower than that of those in group 2 (P = 0.0006). Cox's proportional hazard model revealed that cell culture capability was an independent prognostic factor (risk ratio, 1.98; P = 0.007). Univariate logistic regression analysis revealed that cell culture capability had associations with the following molecular biological factors: cyclin D1, p53, murine double minute 2, p27, and fragile histidine triad gene (P < 0.05). However, multivariate logistic regression analysis revealed that p53 protein accumulation and MDM2 protein expression predict establishment of cell line in ESCC (odds ratio, 7.72 and 8.62, respectively). Conclusions: Cell culture capability is a significant prognostic factor in ESCC. p53 and MDM2 may have a crucial role in the establishment of ESCC cell lines.
引用
收藏
页码:243 / 249
页数:7
相关论文
共 50 条
  • [41] Immunotherapy for Esophageal Squamous Cell Carcinoma
    Takashi Kojima
    Toshihiko Doi
    Current Oncology Reports, 2017, 19
  • [42] Angiogenesis in esophageal squamous cell carcinoma
    Takebayashi, Y
    Natugoe, S
    Baba, M
    Fukumoto, T
    Takao, S
    Akiba, S
    Akiyama, SI
    Aikou, T
    ONCOLOGY REPORTS, 1998, 5 (02) : 401 - 404
  • [43] ESOPHAGEAL SQUAMOUS-CELL CARCINOMA
    SERRA, LB
    BRITISH JOURNAL OF SURGERY, 1981, 68 (04) : 292 - 292
  • [44] MicroRNAs and Esophageal Squamous Cell Carcinoma
    Matsushima, Kayoko
    Isomoto, Hajime
    Kohno, Shigeru
    Nakao, Kazuhiko
    DIGESTION, 2010, 82 (03) : 138 - 144
  • [45] Chemoprevention of esophageal squamous cell carcinoma
    Stoner, Gary D.
    Wang, Li-Shu
    Chen, Tong
    TOXICOLOGY AND APPLIED PHARMACOLOGY, 2007, 224 (03) : 337 - 349
  • [46] Immunotherapy for Esophageal Squamous Cell Carcinoma
    Kojima, Takashi
    Doi, Toshihiko
    CURRENT ONCOLOGY REPORTS, 2017, 19 (05)
  • [47] Esophageal Squamous Cell Carcinoma in Cats
    Abdalla, Daniella Correa
    Cobucci, Gustavo Carvalho
    Souza, Fernanda Rezende
    Cunha Lacreta Junior, Antonio Carlos
    Wouters, Flademir
    Barth Wouters, Angelica Terezinha
    Raymundo, Djeison Lutier
    Varaschin, Mary Suzan
    ACTA SCIENTIAE VETERINARIAE, 2022, 50
  • [48] Epidemiology of esophageal squamous cell carcinoma
    刘媛
    王安辉
    WANG Bo
    ZHU QingHao
    SHANG QingChao
    LI Bo
    HU ZhiHao
    ZHANG GuanWen
    转化医学电子杂志, 2017, 4 (05) : 25 - 28
  • [49] Genomics of Esophageal Squamous Cell Carcinoma
    Lowe, Anson W.
    Moseley, Richard H.
    GASTROENTEROLOGY, 2016, 150 (05) : 1050 - 1050
  • [50] MMR markers correlate with clinical outcome in patients with esophageal squamous cell carcinoma
    Yamauchi, Takuro
    Fujishima, Fumiyoshi
    Tsunokake, Junichi
    Kunimitsu, Atsushi
    Akaishi, Ryujiro
    Ozawa, Yohei
    Fukutomi, Toshiaki
    Okamoto, Hiroshi
    Sato, Chiaki
    Taniyama, Yusuke
    Kamei, Takashi
    Ichinohasama, Ryo
    Sasano, Hironobu
    INTERNATIONAL JOURNAL OF BIOLOGICAL MARKERS, 2023, 38 (02): : 105 - 113